What type and duration of antibiotics are recommended for a patient with bullous impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bullous Impetigo

Recommended Antibiotic Type and Duration

For bullous impetigo, use oral cephalexin 25-50 mg/kg/day divided into 4 doses (or dicloxacillin at the same dosing) for 7 days as first-line therapy, switching to clindamycin or trimethoprim-sulfamethoxazole if MRSA is suspected. 1

Antibiotic Selection Algorithm

First-Line Therapy for Presumed MSSA

  • Cephalexin is the preferred first-line oral antibiotic at 25-50 mg/kg/day divided into 4 doses for 7 days 1
  • Dicloxacillin is an equally effective alternative at 25-50 mg/kg/day divided into 4 doses for 7 days 1
  • Both agents demonstrated equal efficacy in treating staphylococcal bullous impetigo, with prompt clearing of lesions within the first week 2

MRSA Coverage When Indicated

  • Clindamycin 20-30 mg/kg/day divided into 3 doses for 7 days should be used when MRSA is suspected or confirmed 1, 3
  • Trimethoprim-sulfamethoxazole (SMX-TMP) 8-12 mg/kg/day (based on trimethoprim component) divided into 2 doses for 7 days is an alternative MRSA-covering option 1
  • Doxycycline 2-4 mg/kg/day divided into 2 doses for 7 days can be used in children over 8 years old when MRSA is suspected 1

Alternative Oral Options

  • Co-amoxiclav (amoxicillin-clavulanic acid) for 7 days is an acceptable alternative that covers both S. aureus and S. pyogenes 1
  • This is particularly useful when dicloxacillin or cephalexin are not suitable 1

Critical Duration Point

The standard duration for oral antibiotic therapy is 7 days, not the shorter 5-day course used for topical agents. 1, 3

Important Clinical Considerations

Why Bullous Impetigo Requires Specific Therapy

  • Bullous impetigo is exclusively caused by toxin-producing Staphylococcus aureus, unlike non-bullous impetigo which may involve Streptococcus pyogenes 1
  • This makes anti-staphylococcal coverage essential 4

Antibiotics to Avoid

  • Penicillin alone is seldom effective for impetigo and should only be used when cultures confirm streptococci alone 1
  • Amoxicillin alone should not be used because it lacks adequate coverage against S. aureus 1
  • Only 2 of 64 staphylococcal strains in one study were susceptible to penicillin G 2

When to Consider MRSA Coverage

  • In areas with high MRSA prevalence, empiric therapy should cover MRSA until culture results are available 1
  • Consider obtaining cultures if there is treatment failure, MRSA is suspected, or in cases of recurrent infections 3

Special Population Considerations

Pediatric Patients

  • Tetracyclines (doxycycline) should be avoided in children under 8 years due to the risk of dental staining 1, 3

Pregnant Patients

  • Cephalexin can be considered a safe alternative for pregnant patients 1, 3

Penicillin-Allergic Patients

  • Clindamycin or macrolides can be used, though resistance rates to erythromycin are rising 1
  • Avoid cephalosporins if type 1 hypersensitivity (anaphylaxis/hives) to β-lactams exists 3

Common Pitfalls to Avoid

  • Do not use topical therapy alone for bullous impetigo with large bullae or extensive disease—oral antibiotics are required 4
  • Do not assume 5 days is sufficient—the standard oral antibiotic duration is 7 days, not 5 1, 3
  • Reassess by 3-5 days if no improvement occurs, considering MRSA infection, deeper infection, non-compliance, or antibiotic resistance 3

References

Guideline

Impetigo Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Impetigo on Hand Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.